S
605033
vs
S
Shanghai Composite
Over the past 12 months, Shaanxi Meibang Pharmaceutical Group Co Ltd has outperformed Shanghai Composite, delivering a return of +27% compared to the Shanghai Composite's +23% growth.
Stocks Performance
605033 vs Shanghai Composite
Performance Gap
605033 vs Shanghai Composite
Performance By Year
605033 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shaanxi Meibang Pharmaceutical Group Co Ltd
Glance View
Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pesticide preparations. The company is headquartered in Xi'An, Shaanxi and currently employs 933 full-time employees. The company went IPO on 2021-09-16. The firm's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
